Filing Flows › Kewaunee Scientific (KEQU) › Q4 FY26 › vs Q3 FY26
Kewaunee Scientific (KEQU) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Kewaunee Scientific's revenue rose $2.0M (+3%) from $69.4M in Q3 FY26 to $71.4M in Q4 FY26. Gross margin 29.8% against 26.7% (+3.0 pts).
Kewaunee Scientific, Q4 FY26: revenue $71.4M (-8% year over year), operating margin 7.3%, net earnings $3.4M, operating cash flow $5.5M. The chart draws each line against Q3 FY26, the increases inside each band.
Margins
| Q4 FY26 | Q3 FY26 | Change | |
|---|---|---|---|
| Gross margin | 29.8% | 26.7% | +3.0 pts |
| Operating margin | 7.3% | 3.7% | +3.6 pts |
| Net margin | 4.7% | 1.0% | +3.7 pts |
| Free cash flow margin | 6.3% | 15.8% | -9.5 pts |
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $71.4M | $69.4M | $2.0M | +3% |
| Gross profit | $21.2M | $18.5M | $2.7M | +15% |
| Cost of revenue | $50.2M | $50.9M | −$699K | -1% |
| Operating profit | $5.2M | $2.6M | $2.6M | +102% |
| Operating expenses | $16.0M | $16.0M | $66K | +0.4% |
| Pre-tax earnings | $4.8M | $1.6M | $3.2M | +197% |
| Other expense, net | $460K | $978K | −$518K | -53% |
| Net earnings | $3.4M | $692K | $2.7M | +390% |
| Minority interests | $304K | $384K | −$80K | -21% |
| Income tax | $1.1M | $528K | $536K | +102% |
| Depreciation & amortization | $1.6M | $1.6M | −$42K | -3% |
| Share-based compensation | $502K | $542K | −$40K | -7% |
| Working capital & other | $15K | $8.8M | −$8.8M | -100% |
| Operating cash flow | $5.5M | $11.6M | −$6.2M | -53% |
| Free cash flow (OCF − capex) | $4.5M | $11.0M | −$6.4M | -59% |
| Capital expenditures | $928K | $668K | $260K | +39% |
Questions
How much did Kewaunee Scientific's revenue grow quarter over quarter in Q4 FY26?
Kewaunee Scientific's revenue rose $2.0M (+3%) from $69.4M in Q3 FY26 to $71.4M in Q4 FY26. Gross margin 29.8% against 26.7% (+3.0 pts).